BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 4.4800 |
| Open | 4.5900 |
| Bid | 4.4100 x 300 |
| Ask | 4.4400 x 1000 |
| Day's Range | 4.4200 - 4.6700 |
| 52 Week Range | 4.0300 - 8.9600 |
| Volume | |
| Avg. Volume | 3,257,850 |
| Market Cap | 918.173M |
| Beta (5Y Monthly) | 1.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to...
© 2024 Yahoo. All rights reserved.